| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/05/2008 | CA2218161C Peptide compositions with growth factor-like activity |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 01/31/2008 | WO2008013631A2 Composition for the enterosorption and management of toxins comprising a calcium aluminosilcilate clay |
| 01/31/2008 | WO2008013473A1 Disease treating method |
| 01/31/2008 | WO2008013280A1 Substituted spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013277A1 Fused ring spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013213A1 Prodrug of cinnamide compound |
| 01/31/2008 | WO2008013062A1 Methioninase inhibitor and composition and food or drink containing the same |
| 01/31/2008 | US20080027413 Blood Products from Mesenchymal Stem Cells |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027224 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027146 Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases |
| 01/31/2008 | US20080027133 Use of chromen-4-one derivatives |
| 01/31/2008 | US20080027130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 01/31/2008 | US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure |
| 01/31/2008 | US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 01/31/2008 | US20080027114 Active Agent Combinations with Insecticidal and Acaricidal Properties |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027097 Pharmaceutical drug candidates and methods for preparation thereof |
| 01/31/2008 | US20080027086 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 01/31/2008 | US20080027079 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027054 4-Substituted quinolines as antitumor agents |
| 01/31/2008 | US20080027053 Antimicrobial oxazolidinone prodrugs |
| 01/31/2008 | US20080027044 Prodrug antibiotic screens |
| 01/31/2008 | US20080027042 Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080027020 Human Neuropeptide Receptor |
| 01/31/2008 | US20080027018 Electrotransfer of nucleic acid into tissue cells |
| 01/31/2008 | US20080027015 Methods and Materials for Modulating Enac-Beta |
| 01/31/2008 | US20080027005 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/31/2008 | US20080027003 Peptides Useful for Treating Gnrh Associated Diseases |
| 01/31/2008 | US20080026999 Dehydration, cyclization of peptide; prevention, therapy for bacteria infections; amino acid sequences |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
| 01/31/2008 | US20080026989 Human Ependymin |
| 01/31/2008 | US20080026985 Control of gene expression |
| 01/31/2008 | US20080026444 Process For Producing Protein-Polymer Complex |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026083 Antimicrobial and pesticidal compositions and methods comprising reduced monoterpene oil extracted from myrtaceae |
| 01/31/2008 | US20080026077 Methods and compositions of gene delivery agents for systemic and local therapy |
| 01/31/2008 | US20080026061 Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
| 01/31/2008 | US20080026059 Methods of Reducing Degradant Formation in Pharmaceutical Compositions of Varenicline |
| 01/31/2008 | US20080026051 Pharmaceutical form having a two-layer separating layer |
| 01/31/2008 | US20080026040 Active agent-releasing dosage forms |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026007 Potentiation of the immune response |
| 01/31/2008 | US20080026003 Methods for inhibiting pain |
| 01/31/2008 | US20080025995 Cross-Placenta Delivery System |
| 01/31/2008 | US20080025983 Methods of screening based on the EGF receptor crystal structure |
| 01/31/2008 | US20080025978 High affinity ligand for p75 neurotrophin receptor |
| 01/31/2008 | US20080025977 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 01/31/2008 | US20080025967 Method and Kit for Detecting Proliferative Diseases Causing Sclerosis, Preventive and/or Remedy for Proliferative Diseases Causing Sclerosis and Method and Kit for Identifying Substance Efficacious in Preventing and/or Treating Proliferative Diseases Causing Sclerosis |
| 01/31/2008 | US20080025965 Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein levels |
| 01/31/2008 | US20080025960 Detergents with stabilized enzyme systems |
| 01/31/2008 | US20080025957 Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them |
| 01/31/2008 | US20080025941 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | US20080025921 Conductance of Improperly Folded Proteins Through the Secretory Pathway And Related Methods For Treating Disease |
| 01/31/2008 | US20080025920 Methods of treating hot flashes with formulations for transdermal or transmucosal application |
| 01/31/2008 | US20080025919 Benzoylguanidine salt and hydrates thereof |
| 01/31/2008 | US20080025914 Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug |
| 01/31/2008 | CA2658923A1 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes |
| 01/31/2008 | CA2658921A1 Fused ring spiroketal derivative and use thereof as anti-diabetic drug |
| 01/31/2008 | CA2658037A1 Prodrug of cinnamide compound |
| 01/31/2008 | CA2656239A1 Composition and methods for the enterosorption and management of toxins |
| 01/30/2008 | EP1882684A1 Pyrrolidine derivative or salt thereof |
| 01/30/2008 | EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines |
| 01/30/2008 | EP1468110A4 Molecular signatures of commonly fatal carcinomas |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | CN101115763A Novel polyphenol glycoside derived from acerola |
| 01/30/2008 | CN101115483A Pharmaceutical composition containing fbpase-inhibiting agent |
| 01/30/2008 | CN101113156A Method for preparing cape jasmine glycosides standard substance and its analogue |
| 01/30/2008 | CN101113141A Optical active N-(alpha-mercapto radical propionyl group) aminoacetic acid |
| 01/30/2008 | CN101112548A Chinese traditional medicine preparations for treating postpartum night sweating |
| 01/30/2008 | CN101112547A Chinese traditional medicine preparations for treating postpartum spontaneous sweating |
| 01/30/2008 | CN101112543A Ancient prescription Chinese traditional medicine for treating hernia |
| 01/30/2008 | CN101112236A Health products having a hypoxia-tolerance function |
| 01/30/2008 | CN100365111C Fresh cordyceps militaris wine and its making process |
| 01/30/2008 | CN100364991C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
| 01/30/2008 | CN100364602C Quality control method of scourge repelling capsule |
| 01/30/2008 | CN100364559C Method for preparing oral liquid of several micron powders for reducing blood sugar and anti-fatigue |
| 01/30/2008 | CN100364527C Composition of vitamin C and arginine and its application |
| 01/30/2008 | CN100364499C Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 01/30/2008 | CN100364425C Method for preparing yin-nourishing health-preserving milk tablet with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomon |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |
| 01/29/2008 | US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323489 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester |
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323481 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |